Infectious Disease Doctors in Evansville, IN Accepting Medicare

4 Infectious Disease doctors found. Showing 1 - 4

Mubashir A Zahid, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 520 Mary St Ste 230, Evansville, IN 47710 Phone: 812-450-8600    Fax: 812-450-8151

Iass El Lakkis, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 520 Mary St Ste 230, Evansville, IN 47710 Phone: 812-450-8600    Fax: 812-450-8151

Emilian F Armeanu, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 350 W Columbia St, Suite 440, Evansville, IN 47710 Phone: 812-893-1749    Fax: 812-490-6199

Dr. Jose H Salgado, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3801 Bellemeade Ave Ste 330, Evansville, IN 47714 Phone: 812-485-1788    Fax: 812-485-1714

News Archive

Nanotechnology drug kills brain-tumor cells and retards growth of tumor blood vessels

An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier and kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).

Higher fruit and vegetable intake lowers risk of dying from ischaemic heart disease

A European study investigating the links between diet and disease has found that people who consume more fruit and vegetables have a lower risk of dying from ischaemic heart disease - the most common form of heart disease and one of the leading causes of death in Europe.

Prolonged exposure to a pair of antioxidant proteins may fuel liver enlargement

All life is challenged by oxidants - reactive molecules or compounds that remove electrons from other molecules - often with adverse effect, commonly referred to as oxidative stress.

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.

High-fat, low-carb diets may help control epilepsy

Diets high in fat and low in carbohydrates, such as the ketogenic or modified Atkins diet, may reduce seizures in adults with tough-to-treat epilepsy, according to a review of the research published in the October 29, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

Read more Medical News

› Verified 8 days ago